What medications should be given to a patient presenting to the Emergency Room (ER) with severe asthma?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Medications for Severe Asthma in the Emergency Room

For patients presenting with severe asthma to the emergency room, immediate treatment should include oxygen therapy (40-60%), nebulized beta-agonists (salbutamol 5 mg or terbutaline 10 mg), systemic corticosteroids (prednisolone 30-60 mg or IV hydrocortisone 200 mg), and ipratropium bromide 0.5 mg for severe cases. 1, 2

Initial Assessment of Severity

  • Assess for features of severe asthma: inability to complete sentences in one breath, respiratory rate >25/min, pulse >110/min, and peak expiratory flow (PEF) <50% of predicted 1
  • Look for life-threatening features: silent chest, cyanosis, feeble respiratory effort, bradycardia, hypotension, exhaustion, confusion, or coma 1
  • Measure oxygen saturation and PEF to objectively assess severity 1, 3

First-Line Medications

  • Oxygen therapy: Administer 40-60% oxygen in all cases of severe asthma 1
  • Beta-agonists: Give nebulized salbutamol 5 mg or terbutaline 10 mg via oxygen-driven nebulizer 1
    • If nebulizer unavailable, administer 2 puffs of beta-agonist via large volume spacer and repeat 10-20 times 1
    • Monitor response 15-30 minutes after nebulizer treatment 1
  • Systemic corticosteroids: Administer early in treatment 2
    • Oral prednisolone 30-60 mg or intravenous hydrocortisone 200 mg 1
    • Clinical benefits may not be apparent for 6-12 hours, making early administration crucial 4, 5

Additional Medications for Severe Cases

  • Ipratropium bromide: Add 0.5 mg to nebulized beta-agonist for severe exacerbations 1, 2
    • Combination with beta-agonists decreases time in the emergency department and hospitalization rates 5
    • Benefits are not sustained after hospital admission 5
  • Aminophylline: Consider 250 mg administered intravenously over 20 minutes for life-threatening features 1
    • Use with caution if patient is already taking theophyllines 1
  • Epinephrine (adrenaline): Reserved for catastrophic, sudden severe asthma when other treatments have failed 2
    • Administer 0.5 mg via subcutaneous injection 2

Medication Administration Considerations

  • Beta-agonists can be administered by continuous nebulization (CN) or bolus nebulization (BN) with equal efficacy 6
  • Standard dosing of albuterol (2.5 mg) every 20 minutes is as effective as higher doses (7.5 mg) for most patients 7
  • Pressurized metered-dose inhalers (pMDI) with spacers can be as effective as nebulizers when used with appropriate dosing schemes 8
  • Monitor for paradoxical bronchospasm with beta-agonists, which can be life-threatening and requires immediate discontinuation 9

Monitoring Response and Follow-up

  • Reassess 15-30 minutes after nebulizer treatment 1
  • If signs of acute severe asthma persist:
    • Arrange hospital admission 1
    • Repeat nebulized ipratropium 0.5 mg or give subcutaneous terbutaline 1
  • For patients with improving symptoms but PEF still 50-75% of predicted:
    • Continue treatment with beta-agonists 1
    • Ensure prednisolone has been administered 1
    • Observe for at least 60 minutes before considering discharge 1

Common Pitfalls and Caveats

  • Underuse of corticosteroids is a common factor in preventable asthma deaths 1
  • Physicians' subjective assessments of airway obstruction are often inaccurate; rely on objective measures like PEF 4
  • Patients who subsequently require admission typically show a diminished response to the first beta-agonist administration 7
  • Fatalities have been reported with excessive use of inhaled sympathomimetic drugs 9
  • Patients with decreased responsiveness to initial treatment may need admission regardless of medication adjustments 7

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Asthma Attacks with Epinephrine

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment of Dry Sore Throat in Asthmatic Patients Hospitalized for Exacerbation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Chapter 14: Acute severe asthma (status asthmaticus).

Allergy and asthma proceedings, 2012

Research

Acute severe asthma (status asthmaticus).

Allergy and asthma proceedings, 2019

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.